(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.54%) $79.69
(0.48%) $2.31
(0.62%) $2 354.90
(0.85%) $28.61
(0.23%) $993.10
(-0.03%) $0.927
(-0.16%) $10.85
(-0.02%) $0.798
(0.00%) $92.54
2.00% $ 82.73
@ $82.43
Emitido: 9 may 2024 @ 15:00
Retorno: 0.36%
Señal anterior: may 9 - 11:19
Señal anterior:
Retorno: 0.40 %
Live Chart Being Loaded With Signals
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally...
Stats | |
---|---|
Volumen de hoy | 1.91M |
Volumen promedio | 3.60M |
Capitalización de mercado | 37.76B |
EPS | $0 ( 2024-04-30 ) |
Próxima fecha de ganancias | ( $0.970 ) 2024-07-23 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.05 |
ATR14 | $1.450 (1.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Jimenez Frank R | Buy | 1 315 | Common Stock, par value $0.01 per share |
2024-04-01 | Rott Roland | Sell | 837 | Common Stock, par value $0.01 per share |
2024-03-15 | General Electric Co | Sell | 14 000 000 | Common stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 195 | Common Stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 285 | Common Stock, par value $0.01 per share |
INSIDER POWER |
---|
-97.67 |
Last 99 transactions |
Buy: 735 929 | Sell: 57 991 119 |
Volumen Correlación
GE HealthCare Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
GE HealthCare Correlación - Moneda/Commodity
GE HealthCare Finanzas
Annual | 2023 |
Ingresos: | $19.55B |
Beneficio Bruto: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2023 |
Ingresos: | $19.55B |
Beneficio Bruto: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2022 |
Ingresos: | $18.34B |
Beneficio Bruto: | $7.18B (39.14 %) |
EPS: | $4.22 |
FY | 2021 |
Ingresos: | $17.59B |
Beneficio Bruto: | $7.17B (40.80 %) |
EPS: | $4.94 |
Financial Reports:
No articles found.
GE HealthCare
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico